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and characterization of 24-h circulating CT-1 profiles in
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ABSTRACT: Cardiotrophin (CT)-1 is a regulator of glucose and lipid homeostasis. In the present study, we analyzed
whetherCT-1 alsoacts toperipherally regulatemetabolic rhythmsandadipose tissue core clockgenes inmice.Moreover,
the circadian pattern of plasma CT-1 levels was evaluated in normal-weight and overweight subjects. The circadian
rhythmicity of oxygen consumption rate (VO2) was disrupted in aged obese CT-1-deficient (CT-1
2/2) mice (12 mo).
Although circadian rhythms of VO2 were conserved in young lean CT-1
2/2mice (2mo), CT-1 deficiency caused a phase
shift of the acrophase.Most of the clock genes studied (Clock,Bmal1, andPer2) displayed a circadian rhythm in adipose
tissue of both wild-type (WT) and CT-12/2 mice. However, the pattern was altered in CT-12/2 mice toward a lower
percentage of the rhythm or lower amplitude, especially forBmal1 andClock.Moreover, CT-1mRNA levels in adipose
tissue showed significant circadian fluctuations in young WT mice. In humans, CT-1 plasma profile exhibited a 24-h
circadian rhythm in normal-weight but not in overweight subjects. The 24-h pattern of CT-1 was characterized by a
pronounced increase during the night (from 02:00 to 08:00). These observations suggest a potential role for CT-1 in the
regulationofmetabolic circadian rhythms.—Lo´pez-Yoldi,M., Stanhope,K.L.,Garaulet,M.,Chen,X.G.,Marcos-Go´mez,
B., Carrasco-Benso,M. P., SantaMaria, E.M., Escote´, X., Lee, V., Nunez,M. V.,Medici, V., Martı´nez-Anso´, E., Sa´inz, N.,
Huerta, A. E., Laiglesia, L.M., Prieto, J.,Mart´ınez, J. A., Bustos,M., Havel, P. J.,Moreno-Aliaga,M. J. Role of cardiotrophin-1
in the regulation of metabolic circadian rhythms and adipose core clock genes in mice and characterization of 24-h
circulatingCT-1profiles innormal-weightandoverweight/obesesubjects. FASEBJ. 31, 1639–1649 (2017).www.fasebj.org
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Obesity [defined as a bodymass index (BMI).30 kg/m2]
is a growing public health problem that has reached epi-
demic proportions in many developed and developing
countries (1). Among the different causes of obesity,
the modern human lifestyle, including dietary com-
ponents and timing and altered patterns of physical
activity, can contribute to desynchrony between in-
ternal rhythms and external cues in humans. This
disruption has been proposed to be an important
contributor to the onset ofmetabolic syndrome (MetS),
obesity and type 2 diabetes (2–4). In this context, it has
been described that different phenomena, such as
short sleep duration (5), shift work (6), and jet lag (7),
among others, could be involved in the development
of obesity and type 2 diabetes. In addition, other fac-
tors, such as altered patterns of physical activity (8)
and the time of feeding (9), can contribute to the
desynchrony of circadian rhythms.
ABBREVIATIONS: BMI, body mass index; CD, chronodisruption; CT-1,
cardiotrophin-1; FFA, free fatty acid; HDL-C, high-density lipoprotein-
cholesterol; HFD, high-fat diet; HOMA, homeostasis model assessment;
LDL-C, low-density lipoprotein-cholesterol; MetS, metabolic syndrome;
PBST, PBS Tween; PF, pair fed; rCT-1, recombinant protein CT-1; REE,
resting energy expenditure; SCN, suprachiasmatic nucleus; TAG, tri-
acylglycerol; VO2, oxygen consumption; WT, wild-type
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Recent studies have suggested important interactions
between internal circadian rhythms (i.e., clock) and the
regulation of energy metabolism. Indeed, disruption of
circadian rhythms (chronodisruption; CD) may result in
desynchrony, which impairs metabolic homeostasis and
may contribute to the development of obesity and MetS
(10, 11). In mammals, a circadian molecular complex is in-
tegrated by a central pacemaker in the suprachiasmatic
nucleus (SCN) of the hypothalamus and peripheral oscil-
lators are present in most tissues and cells, including adi-
pose tissue (12). Peripheral clocks are controlled by the
central clock to ensure a temporal synchronization of
physiologic events (13, 14). The positive limb of the mo-
lecular core clock machinery is composed and directed by
the CLOCK and BMAL1 proteins, which hetero-
dimerize to regulate the expression of the negative
elements and circadian genes. On the other hand, the
negative limb comprises PER and CRY, which form
heterodimers and repress their own transcription by
negatively regulating the transcriptional activity of
the CLOCK:BMAL1 heterodimer (15). The importance
of the clock gene network in the control of metabolism
and energy balance has become clear, given that mice
in which some of these genes are genetically inacti-
vated have been reported to develop obesity and
related metabolic disorders (16, 17). In this context, a
previous study demonstrated that clock mutant mice
exhibit disrupted diurnal feeding rhythm, being hy-
perphagic and obese, and exhibit elements of meta-
bolic syndrome (18).
Cardiotrophin (CT)-1 belongs to the IL-6 family of cy-
tokines (19). A study by our group has revealed that CT-1
is a key regulator of energy homeostasis and of glucose
and lipid metabolism (20). CT-1 null (CT-12/2) mice de-
velop adult-onset obesity, insulin resistance, and hyper-
cholesterolemia, despite reduced energy intake (20). In
addition, chronic administrationof recombinant (r)CT-1 to
mice reduces bodyweight and improves insulin resistance
in ob/ob and in high-fat–fed obese mice by reducing food
intake and enhancing energy expenditure. However,
some studies have described that circulating levels of CT-1
are higher in obese subjects (21) withmetabolic syndrome
(19). Taking into account the beneficial effects of CT-1 on
energy homeostasis, as well as on glucose and lipid me-
tabolism, the observed elevation of CT-1 in obesity may
represent a compensatorymechanismtoattenuateobesity-
related metabolic dysfunctions.
Adipose tissue has been established as a peripheral
oscillator capable of modulating central core clock genes
(22). However, the regulation of the peripheral clock and
the clock-controlled genes present in the adipose depots
remains unclear (23). In this context, it has been proposed
that several molecules secreted by adipose tissue such as
leptin and adiponectin, which are important metabolic
mediators, could be peripheral regulators of the circadian
clocks in the brain and peripheral organs/tissues (24, 25).
Some of these adipokines are controlled by clock genes,
and their expression in adipose tissue exhibit diurnal
variation (26–28). Circulating concentrations of leptin,
adiponectin, and other hormones involved in metabolic
regulation, suchasghrelin and IL-6, exhibit 24-hvariations
that have circadian and meal-related patterns (24, 29,
30). There is no information available regarding the
potential involvement of CT-1 in the regulation of core
clock genes in adipose tissue, and the potential for di-
urnal variations of circulating CT-1 in humans has not
been investigated.
Therefore, the purpose of the present study was to
analyze whether CT-1 deficiency would regulate cir-
cadian rhythmicity and the expression of core circa-
dian clock genes in white adipose tissue in mice.
Moreover, we tested the potential circadian rhythm of
CT-1 mRNA levels in adipose tissue. Finally, we
sought to evaluate whether there is a circadian rhythm
of CT-1 concentrations in plasma of normal-weight
and overweight/obese men and women.
MATERIALS AND METHODS
Animal studies
Recombinant protein CT-1
rCT-1 was obtained as described in Beraza et al. (31), and con-
tained ,0.04 ng LPS per 1 mg protein, as determined by the
Limulusamoebocyte lysateassay (Cambrex,EastRutherford,NJ,
USA).
Animal models
CT-12/2mice CT-12/2micewere generated asdescribedby
Oppenheim et al. (32). We analyzed mice backcrossed into a
C57BL/6J background for 11 generations (provided by Diane
Pennica; Genentech, South San Francisco, CA, USA, and Bettina
Holtmann, University of Wu¨rzburg, Germany). C57BL/6J mice
were originally obtained from The Jackson Laboratory (Bar
Harbor, ME, USA) andmaintained under specific pathogen-free
conditions and controlled temperature and humiditywith a 12-h
light (08:00–20:00), 12-h dark (20:00–08:00) cycle. Body weight
and food intake were measured in wild-type (WT) and CT-12/2
mice from 2 to 12 mo old. At the end of the different experi-
mental periods (2 and 12mo),WT andCT-12/2 animalswere
euthanized in parallel between 8 and 11 AM after 16 h of food
withdrawal. To better characterize the role of CT-1 deficiency
on the regulation of peripheral clocks, we obtained epidid-
ymal fat samples fromWTandCT-12/2mice (2moold) at the
following times (08:00, 14:00, 20:00, and 02:00). On the other
hand, to test the effects of rCT-1 treatment, CT-12/2 animals
were divided into 3 subgroups: one that received rCT-1 IV
(0.2 mg/kg/d) for 6 d, another given saline instead of rCT-1,
and a pair-fed (PF) group given saline. In this case, animals
were euthanized between 8 and 11 AM after remaining unfed
for 16 h. Epididymal adipose depots were excised and kept
at 280°C for subsequent analysis. All experimental proce-
dures were approved by the University of Navarra Ethics
Committee.
Prolonged administration of rCT-1 to ob/ob mice Eight-
week-old ob/ob mice were obtained from the Janvier Laboratory
(Le Genest St. Isle, France). C57BL/6J mice were obtained from
Harlan Laboratories (Barcelona, Spain) andwere placed on a high-
fat diet (HFD; 60%kcal fromfat, 20% fromcarbohydrates, and20%
fromprotein; ResearchDiets,NewBrunswick,NJ,USA) ad libitum.
BothWTandob/obmiceweremaintainedunderspecificpathogen-
free conditions and controlled temperature and humidity with a
12-h light (08:00–20:00), 12-h dark (20:00–08:00) cycle. Ob/ob
mice were divided into 3 groups, one that received rCT-1 in-
travenously (0.2 mg/kg/d) for 10 d and fed ad libitum, another
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group given saline instead of rCT-1 and fed ad libitum, and a PF
group given saline and receiving the same amount of food as
ingested by the rCT-1 treated animals. This group is necessary
to distinguish what rCT-1 actions are likely to be independent
of the effects of rCT-1 on food intake. Food intake and body
weight were measured daily. All groups of animals were eu-
thanized in parallel between 8 and 11 AM after remaining unfed
overnight. Epididymal fat depots were excised, weighed, and
kept at 280°C for subsequent analysis (20). All experimental
procedureswere approved by theUniversity of Navarra Ethics
Committee.
Body composition analysis
Whole-animal body composition was measured in live con-
scious animals with Quantum molecular resonance technol-
ogy (EchoMRI-100-700; EchoMedical Systems, Houston, TX,
USA).
Biochemistry
All serum measurements were performed in samples collected
frommice leftunfed for 16h,unless otherwise indicated, byusing
a Cobas Mira Autoanalyzer (Roche Diagnostic, Basel, Switzer-
land) (20). Insulinwas analyzedwith amurine-specific ELISAkit
fromEMD-Millipore (Billerica,MA,USA)andCrystalChem, Inc.
(Downers Grove, IL, USA).
Whole-body oxygen consumption
As previously reported, 24-h whole-body oxygen consumption
(VO2) wasmeasured inWT andCT-1
2/2mice (2 and 12mo old)
using the Oxylet System (Panlab, Spain) (20).
Real-time PCR
Total RNA was extracted from epididymal fat depots by using
Trizol reagent (Thermo Fisher Scientific, Carlsbad, CA, USA),
according to the manufacturer’s instructions. RNA concentra-
tions and quality were measured by Nanodrop Spectropho-
tometer 1000 (Thermo Fisher Scientific, Waltham, MA, USA).
RNAwas then incubatedwith anRNAse-freekitDNase (Thermo
Fisher Scientific,Austin, TX,USA) for 30min at 37°C.RNA (2mg)
was reverse transcribed into complementaryDNAwithMoloney
murine leukemia virus reverse transcriptase (Thermo Fisher
Scientific). mRNA levels were determined by using predesigned
TaqMan Assays-on-Demand (Clock: Mm00455959_m1; Bmal:
Mm00500226_m1;Per2:Mm00478113_m1;Cry1:Mm00514392_m1;
Ctf1: Mm00432772_m1). Taqman Universal Master Mix (Thermo
Fisher Scientific) was provided by the same supplier. The reaction
conditions were followed as described by the manufacturer’s in-
structions. Amplification and detection of specific products were
performed on the Prism 7900HT system (Thermo Fisher Scientific).
mRNA levels were normalized by the housekeeping gene cyclo-
philin (Mm02342430_g1), obtained from Thermo Fisher Scientific.
All sampleswereanalyzedinduplicate.Therelativeexpressionlevel
of each gene was calculated as 22DDCt.
Human study
Subjects
Participants in this study were a subgroup from a U.S. National
Institutes of Health-funded investigation (NCT01103921; http://
www.clinicaltrials.gov/), in which 187 participants assigned to
8 experimental groupswere studied. This paper reports only the
results of baseline samples collected before the dietary sugar
intervention.
Participants were recruited through an internet listing
(Craigslist.com) and local postings of flyers and were inter-
viewed on telephone and in person. Amedical history, complete
blood count, and serum biochemistry panel were obtained to
assess eligibility. Inclusion criteria encompassed men and
women (age18–40yrandBMI18–35kg/m2),witha self-report of
stable body weight during the prior 6 mo. Exclusion criteria in-
cluded diabetes (fasting glucose.125 mg/dl), evidence of renal
or hepatic disease, fasting plasma triacylglycerol (TAG) .400
mg/dl, hypertension (.140/90mmHg), hemoglobin,8.5 g/dl,
and surgery for weight loss. Individuals who smoked, ha-
bitually ingested more than 2 alcoholic beverages per day,
exercised more than 3.5 h/wk at a level more vigorous than
walking, or used thyroid, lipid-lowering, glucose-lowering,
antihypertensive, antidepressant, or weight loss medica-
tions were also excluded.
Methods
The first phase of this study consisted of a 3.5-d inpatient period
during which subjects resided at the University of California,
Davis Clinical and Translational Science Center’s Clinical Re-
search Center, consumed a standardized baseline diet, and par-
ticipated in experimental procedures.
Inpatient diets During d 2 and 3 of the inpatient period,
subjects consumed energy-balanced meals consisting of conven-
tional foods. Daily energy requirements were calculated by the
Mifflin equation. With this equation, the resting energy expendi-
ture (REE) is calculated by using the following formula: REE
(males) = 103weight (kg) + 6.253 height (cm)2 53 age (yr) + 5;
REE (females) = 103weight (kg) + 6.253 height (cm)2 53 age
(yr)2161 (33),with adjustment of 1.3 for activity on thedaysof the
24-h serial blood collections, and adjustment of 1.5 for the other
days. The diet provided 55% energy requirements mainly as low-
fiber complex carbohydrate (i.e., white bread, white rice, regular
pasta), 30% from fat, 15% from protein, and 22 g fiber/2000 kcal.
The timing of inpatient meals and the energy distribution were:
breakfast at 09:00 (25%); lunch at 13:00 (35%); and dinner at 18:00
(40%).
Procedures We performed 24-h serial blood collections (34)
on the third day of the inpatient period. Three fasting blood
samples were collected at 08:00, 08:30, and 09:00. Twenty-nine
postprandial bloodsampleswere collected at 30–60min intervals
until 08:00 the followingmorning. Fastingplasma concentrations
of TAG and total and low- and high-density lipoprotein-
cholesterol (LDL-C and HDL-C) were determined with a Poly-
chem Chemistry Analyzer (PolyMedCo, Inc., Cortland, NY,
USA) with reagents from MedTest DX (Cortlandt Manor, NY,
USA). Glucose concentrations were measured with an auto-
mated glucose analyzer (YSI, Inc. Yellow Springs, OH, USA)
and insulin by radioimmunoassay (EMD-Millipore). Free fatty
acids (FFAs) were assayed with an enzymatic colorimetric as-
say (Wako Chemicals, Richmond, VA, USA) adapted to a
microtiter plate.
Ethics The study was conducted in accordance with experi-
mentalprotocol thatwasapprovedbytheUniversityofCalifornia,
Davis Institutional Review Board, and the participants provided
written informed consent.
Determination of serum CT-1 plasma concentrations
Plasma CT-1 concentrations were measured by ELISA, as de-
scribed previously (35). In brief, human plasma samples were
added to 96-well plates precoated overnight with a rat monoclo-
nal anti-CT-1 antibody (R&D Systems, Minneapolis, MN, USA),
washed with PBS, and blocked in 1% bovine serum albumin
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(BSA)/PBS. Then, samples were incubated overnight at 4°C.
Following incubation, plates were washed 3 times with PBS
Tween-0.05% (PBST) and incubatedwith a rabbit anti-humanCT-
1 antibody (R&D Systems) for 4 h at room temperature. After
incubation, unbound antibodieswerewashed offwith PBST, and
plates were incubated with a peroxidase conjugated rabbit spe-
cific antibody (Pierce, Rockford, IL, USA) added for detection of
the bound anti-CT-1. Finally, plates were washed, and labeled
antibody binding was determined using 3,3,5,5-tetramethylbenzi-
dine substrate. Absorbance was read at 450 nm and CT-1 plasma
concentrationsdeterminedby comparisonwitha standardcurveof
serially diluted recombinant CT-1 in dilution buffer.
Statistical analysis
Data are presented as means 6 SEM. A repeated-measures
ANOVA was performed to analyze significant time-dependent
changes in CT-1 plasma levels during 24 h, as well as during the
light period (from 08:00 to 20:00) and the darkperiod (from20:00
to 08:00). Comparisons between the values for different variables
were analyzed by Student’s t test or Mann-Whitney U test once
the normality had been screened using Kolmogorov-Smirnoff
and Shapiro-Wilk tests. Statistical analyses were performed and
graphs createdwith Prism6 software (Graph-Pad Software, Inc.,
La Jolla, CA, USA) and Stata Statistical Software (Release 12;
StataCorp LP College Station, TX, USA). Overall, a value of
P, 0.05 was indicated significant.
To investigate thepresence of circadian rhythm forVO2 inWT
andCT-12/2 inmice and 24-h circulatingCT-1 concentrations in
humans, a least-squares periodic regression (36) was used to fit
a sinusoidal function to the data (t= 24 h). Cosinor analysiswas
used to characterize the rhythm, calculating its mesor (mean
value of VO2 rhythm fitted to a cosine function), amplitude
[difference between the maximum (or minimum) value of the
cosine function andmesor], acrophase (timing of themaximum
value of the cosine fitted curve relative to local 00:00 h). These
parameters are represented graphically in a polar plot (hourly)
to visualize the characteristics of the rhythm by a vector (cosi-
nor) whose length corresponds to the amplitude and the di-
rection to the acrophase. All the data from all individuals were
used simultaneously to directly estimate the population pa-
rameters (1-step method) using a model that includes a sinu-
soid and a constant for each individual, which corresponds to
the individualmesor, eliminating the effect of interindividual
variation in the estimated global rhythm. A JTK_Cycle
analysis (37) was also performed to better characterize the VO2
rhythmicity in mice and the CT-1 rhythmicity in human
plasma.
RESULTS
CT-12/2 mice exhibit altered metabolic
circadian rhythm and expression of core
clock genes in adipose tissue
As reported (20), CT-12/2 andWTmice had similar body
weights at 2moof age; however,CT-12/2micedeveloped
adult onset obesity (Supplemental Table 1). CT-12/2mice
exhibited decreased energy expenditure and oxygen con-
sumption at 2 mo of age, which preceded and accompa-
nied the development of obesity (20). To determine
whether CT-1 deficiency could also result in disturbances
in circadianpatterns,weanalyzed thedaily rhythmof24-h
VO2 (38) in WT and CT-1
2/2mice at 2 and 12 mo of age.
Parameters imputed from each group were obtained by
cosinor analysis, and defined the characteristics of the
rhythms as mesor, amplitude, acrophase, and percent
rhythm are reported in Fig. 1. Although both young WT
and CT-12/2 mice (2 mo old) exhibited robust circadian
rhythms for VO2 values (P , 0.05), it is important to note
that CT-1 deficiency caused a phase shift characterized
by an advance of;1 h of acrophase (Fig. 1A). Aging per
se (comparisons between WT mice at 2 and 12 mo of
age) lead to CDs characterized by an advance of the
acrophase together with a reduction of the amplitude
of the rhythm (Fig. 1A , B, left panels).Whereas the 24-h
circadian rhythm forVO2 wasmaintained in 12-mo-old
WT mice (Fig. 1B), the circadian rhythm for VO2 was
completely absent in CT-12/2 obese mice, suggesting
that CT-1 deficiency not only promotes obesity, but
also appears to aggravate the CD associatedwith aging
in mice. Similar outcomes were obtained when the
rhythmicity of VO2 was analyzed by JTK_Cycle (Sup-
plemental Table 2).
To testwhether CT-1 deficiency alsomodulatesmRNA
expressionof core clockgenes inperipheralorgans, suchas
adipose tissue, we analyzed 24-h gene expression (08:00,
14:00, 20:00 and 02:00) of Clock, Bmal1, Per2, and Cry1 in
epididymal fat and compared between 2-mo-old WT and
CT-12/2mice fed ad libitum (Fig. 2). The expressions of the
positive elements Clock and Bmal1 mRNA levels were
moderately lower in CT-12/2 animals, significantly differ-
ent (P, 0.05) from theClock levels inWTmice at 02:00 (Fig.
2A) and Bmal1 levels at 08:00 (Fig. 2B, left panel). Cosinor
analysis revealed that Clock and Bmal1 mRNA levels
exhibited circadian rhythmicity in both WT and CT-12/2
mice. However, the pattern was altered in CT-12/2 mice
toward a lower percentage of the rhythm and lower am-
plitude (Fig 2A, B). Per2 expression also exhibited a circa-
dian rhythm inWT and CT-12/2mice, with no significant
differences between both. This rhythm characterized by a
continuous rise during the light period, reached the
acrophase at 20:00. As expected Per2 rhythms (a negative
element of the clock) were in antiphase with Clock and
Bmal1 (positive elements). No significant changes were
observed between WT and CT-12/2 mice (Fig. 2C). The
gene expression of the other negative element Cry1 was
significantly lower (P, 0.05) in CT-1-knockout mice com-
pared with WT during the morning (at 08:00 and 14:00)
(Fig. 2D). Cosinor analyses revealed that the circadian
rhythmicity of Cry1 was observed only in CT-12/2, but
not in WT mice (Fig. 2D). The similarity in body com-
position between the WT and CT-12/2 at 2 mo of age
suggests that the alteration in the circadian patterns is
caused by CT-1 deficiency and it is not a consequence of
increased adiposity.
In 12-mo-old obese CT-12/2mice, the expression of
Clock, Bmal1, Per2, and Cry1 in adipose tissue at
morning timeswere alsomarkedly different from those
in WT mice (Supplemental Fig. 1). However, it is dif-
ficult to discern between the effects derived from CT-1
deficiency and those secondary to the obesity and in-
sulin resistance observed in oldCT-12/2mice and from
induced by aging.
On the other hand, our data suggest that the exogenous
administrationof rCT-1 (0.2mg/kg/d) couldalso regulate
the expression of some peripheral clocks in adipose tissue
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of 2-mo-old CT-12/2 mice (Supplemental Fig. 2) and in
ob/ob mice (Supplemental Fig. 3), further supporting the
involvement of this cytokine in the regulation of adipose
tissue peripheral clocks. However, gene expression was
measured at a single time point, and it is hard to establish
whether the changes observed were a direct effect of the
cytokine or secondary to a potential phase shift of the
rhythm of these core clock genes induced by rCT-1
administration.
Finally, because CT-1 deficiency leads to impairments
in adipose tissueperipheral clockgenes,weaskedwhether
it has adailymRNAexpression rhythm.Thedata revealed
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Figure 1. Cosinor analysis of the 24-h circadian rhythm for VO2 in WT and CT-1
2/2mice at 2 and 12 mo of age. Top: polar (clock-like)
representation of the estimates of the parameters of the rhythm for VO2 in the form of a 24-h clock in WT and CT-1
2/2mice at 2 (A)
and 12 (B) mo of age. Bottom: x–y plot showing the best-ﬁtting waveform proﬁle of the rhythm.
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that adipose tissue CT-1 mRNA levels exhibited signifi-
cant fluctuations throughout the 24-h period and a sig-
nificant circadian rhythm (Fig. 3).
All these observations suggest an involvement of CT-1
in the regulationof the expressionof clockgenes inadipose
tissue in mice.
CT-1 plasma 24-h profiles in normal-weight
and overweight subjects
Table 1 shows the characteristics of the subjects included
in the study. The overweight (group including over-
weight andobese individuals) exhibitedhyperinsulinemia
(P , 0.05) and higher levels of cholesterol (P , 0.01)
than normal-weight subjects, because of increased levels
of LDL-C (P, 0.001). CT-1 levelsweremoderately higher
in overweight/obese than in normal-weight subjects but
the difference was not statistically significant.
When the correlations between plasma CT-1 concen-
trations and anthropometric and biochemical parameters
were analyzed, Spearman’s correlation analysis revealed
thatCT-1 levels correlatedpositivelywithweight (r=0.349;
P = 0.034), waist circumference (r = 0.372; P = 0.023), and
waist/hip ratio (r = 0.398; P = 0.015), but negatively with
LDL-C (r = 20.341; P = 0.039) in normal-weight subjects.
These associations were not observed in the overweight
group (Table 2).
We next focused on analyzing the possible circadian
pattern of circulating CT-1 concentrations in plasma
samples from human subjects. For that purpose, 24-h
profiles for plasma CT-1 were determined in 11 selected
subjects (6 normal weight and 5 overweight/obese)
matched for similar CT-1 plasma levels at baseline
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Figure 2. Daily mRNA expression proﬁles and cosinor analysis of the circadian rhythms for core clock genes. Left: around the
clock gene expression levels of Clock (A), Bmal1 (B), Per2 (C), and Cry1 (D) in epididymal fat of 2-mo-old WT and CT-12/2 mice.
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(characteristics of these 11 subjects are summarized in
Supplemental Table 4). Figure 4A shows the 24-h plasma
CT-1 profile expressed as a percentage of 24-h mean
plasma CT-1 concentrations in both the normal-weight
and overweight groups. Relevant differences in CT-1
patterns during light and dark periods were observed
between both groups. Thus, Fig. 4A shows that during the
light period, CT-1 plasma levels showed significant (P =
0.003) daytime changes characterized by the marked fall
from08:00 to 09:00 in normal-weight individuals,whereas
no significant daytime changes were observed in the
overweight group (P = 0.250). Conversely, CT-1 ex-
cursions during the dark period (from 20:00 to 08:00)
exhibited significant changes (P = 0.007) only in the
overweight subjects without significant modifications
in the normal-weight individuals. It is important to
note that at 02:00, CT-1 levels were significantly lower
in overweight/obese subjects (P , 0.05) than in
normal-weight subjects (Fig. 4A).
A cosinor analysis was performed to evaluate the cir-
cadian rhythm of CT-1. The main parameters defining
the circadian rhythm as mesor, amplitude, relative am-
plitude, acrophase, and percent rhythm are shown in
Fig. 4B and Supplemental Table 5. The results indicate
that the normal-weight group had a significant 24-h cir-
cadian rhythm of CT-1 (Fig. 4B), whereas the rhythmwas
reduced or not significant in the overweight group. These
data were additionally confirmed by the JTK_Cycle anal-
ysis (Supplemental Table 6).
DISCUSSION
Thecurrent studyprovidesevidenceof a roleofCT-1 in the
regulation of circadian rhythms and core clock genes in
adipose tissue. A novel observation from this study is that
24-h circadian rhythms of VO2 were altered in CT-1
2/2
mice comparedwithWTmice at 12moof age. It is possible
that this circadian alteration contributes to the mature-
onset obesity and metabolic disturbances observed in
these animals (20). Although it cannot be concluded
whether theCDobserved in oldCT-12/2mice is a cause
or a consequence of obesity, the fact that young lean
CT-12/2 mice (2 mo) exhibited an early-onset phase
shift of acrophase for VO2 rhythm suggests that CD both
precedes and accompanies development of obesity in the
adult state in these animals.
The lack of CT-1 also dramatically alters the expression
pattern of core clock genes in adipose tissue. Several ob-
servations suggest that disruption of adipose tissue clock
genes could precede the development of obesity in
CT-12/2mice. That the body fat is similar in bothWTand
CT-12/2mice suggests that the alterations of these clock
TABLE 1. Baseline anthropometric and biochemical parameters of normal-weight vs. overweight subjects
Variable
All subjects
n = 84
Normal weight
n = 37
Overweight
n = 47 P
Anthropometric parameter
Age (yr) 26.80 6 0.67 24.85 6 0.82 28.65 6 0.99 ,0.01
Weight (kg) 74.70 6 1.45 65.05 6 1.53 82.29 6 1.59 ,0.0001
BMI (kg/m2) 25.36 6 0.40 22.15 6 0.30 27.88 6 0.40 ,0.0001
Waist (cm) 77.94 6 1.08 70.28 6 1.00 83.96 6 1.17 ,0.0001
Waist/hip ratio 0.79 6 0.01 0.76 0.01 0.81 6 0.01 0.002
Metabolic parameter
Glucose (mg/dl) 90.39 6 0.72 89.19 6 0.97 91.38 6 1.03 0.127
Insulin (mU/L) 13.6 6 1.02 11.31 6 0.67 15.37 6 1.67 0.046
HOMA 2.91 6 0.24 2.39 6 0.15 3.30 6 0.39 0.057
TAG (mg/dl) 102.9 6 4.82 88.52 6 5.12 114.2 6 7.25 0.007
FFA (mM) 0.39 6 0.01 0.37 6 0.02 0.40 6 0.02 0.236
Cholesterol (mg/dl) 156.7 6 3.31 145 6 4.62 165.9 6 4.25 0.001
HDL-C (mg/dl) 45.21 6 1.39 46.77 6 1.78 43.99 6 2.06 0.325
LDL-C (mg/dl) 91.35 6 2.73 80.99 6 3.58 99.51 6 3.58 0.0005
CT-1 baseline (ng/ml) 10.61 6 0.96 9.67 6 1.19 11.34 6 1.44 0.390
Data are means 6 SEM. Underlined values indicate a signiﬁcant difference between normal-weight
and overweight individuals. HOMA: homeostasis model assessment.
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Figure 3. Adipose tissue daily mRNA expression
proﬁle and cosinor analysis of CT-1. Around the
clock gene expression levels of CT-1 in epididymal
fat of 2-mo-old WT mice. Data are means 6 SEM
(n = 4–6). Polar (clock-like) representation of the
estimates of the parameters of the rhythm for CT-1
mRNA in the form of a 24-h clock in WT mice at
2 mo of age.
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genes are specific to CT-1 deficiency and not secondary
to the increased adiposity observed in adult mice.
Moreover, the comparison of the daily rhythms of core
clock gene expression in adipose tissue of young WT
and CT-12/2 mice suggests that there is truly an al-
teration of the core clock gene expression as a conse-
quence of CT-1 deficiency, which is linked to a reduced
percentage of the rhythm, amplitude or both, and es-
pecially for the positive elements Clock and Bmal1. Al-
though, some moderate changes in the acrophase were
observed for Clock and Per2 in CT-12/2 mice, CT-1
deficiency does not seem to cause a phase shift in the
expression of these core clock genes in adipose tissue. It
is important to note that CT2/2mice exhibit decreased
energy expenditure and oxygen consumption at 2 mo
of age, which precedes and accompanies the develop-
ment of obesity (20). Hence, it can be proposed that
alterations in energy expenditure and oxygen con-
sumption observed in youngCT-12/2mice could be, at
least in part, secondary to the disruption of the clock
machinery observed in the adipose tissue of these ani-
mals. It has also been reported that ClockD19 mutant
mice, which express a loss-of-function mutation in the
Clock gene, exhibit features of the metabolic syndrome
(18). Moreover, Cry1/2 deficiency results in an in-
creased vulnerability to obesity induced by an HFD,
despite reduced food intake, and this may be related to
more efficient lipid storage in adipose tissue (17). Adult
CT-12/2 mice also exhibit obesity and increased ex-
pression of lipogenic genes, despite reduced food in-
take compared toWTmice (20). In addition, it has been
reported that Bmal12/2 male and female mice exhibit
increased adiposity on a standard chow diet, but con-
sumption of an HFD does not exaggerate these differences
(39). However, other studies have reported conflicting
outcomes regarding the role of Bmal1 and Cry in obesity
susceptibility (40, 41).
It has been reported that an impairment of peripheral
circadian clocks in adipose tissue and liver precedes the
metabolic abnormalities in ob/ob mice (42). These abnor-
malities were attenuated by leptin treatment, but not by
caloric restriction. On the other hand, we have previously
described that treatment of ob/ob mice with CT-1 pro-
moted body weight loss and fat mass reduction, accom-
panied by a dramatic remodeling in adipose tissue gene
profile (20). Our current data also suggest that exogenous
CT-1 has a potential role as a regulator of adipose tissue
clock gene machinery. However, further studies are
needed to better characterize the relevance of these ob-
servations and, if it exists, a true alteration in the expres-
sion of clock genes mediated by rCT-1 treatment, or it is
secondary to a phase shift of the rhythm. In this context, a
previous study suggested that cardiotrophin-like cytokine
is likely to be an output signal from the SCN, which is
involved in daily rhythms of behavior (43).
Circulating concentrations of many hormones (notably
glucocorticoids and growth hormone) exhibit circadian
and ultradian patterns. As an example for a circulating
cytokine, there are circadian variations of circulating IL-6
concentrations, with lower levels during daytime and
higher levelsduring thenight (44–46). In thepresent study,
circulating CT-1 concentrations also exhibited diurnal
variations and a 24-h circadian rhythm. The most prom-
inent changes of plasma CT-1 concentrations over 24 h
include the increase of plasma levels during the night,
reaching amaximumpeak at 08:00, followed by amarked
decrease that occurs in the morning between 08:00
and 09:00.
It has been proposed that the role of the circadian sys-
tem in the regulation of appetite during sleep/wake cycles
is to serveasamechanismto facilitate the typical overnight
fast (47). A circadian system may be involved in reduced
hunger in themorning, despite aprolongedovernight fast.
Taking into account the previously mentioned properties
ofCT-1 that reduce food intake, it canbehypothesized that
the nocturnal increase in CT-1 during the late night hours
contributes to the regulation of patterns of hunger and
appetite in humans. The observation that CT-1 levels in-
crease during the late night and early morning hours and
then decline fairly soon after awakening suggest a close
relationship with the sleep–wake cycles.
The nocturnal increase in CT-1 has a similar pattern to
the increase of FFAs when lipolysis in adipose tissue is
increased during the night (48), suggesting that the
changes in plasma CT-1 levels may also be related to
metabolic homeostasis during the prolonged fasting that
occurs during the late night and earlymorning hours. In a
previous study, our group reported that CT-1 is a nutri-
tionally regulated gene that increases markedly in several
tissues when mice are subjected to 48-h food withdrawal
and decreases promptly upon refeeding (20). However, it
is important to note that plasmaCT-1 levels do not appear
to be acutely regulated bymeals, given that CT-1 levels do
not change significantly after breakfast, lunch, or dinner.
An interesting observation of the current study is that
the circadian rhythm of CT-1 observed in normal-weight
subjects was not significant in overweight/obese in-
dividuals. Obesity has been associated with a loss of
TABLE 2. Correlation analysis between plasma CT-1 and
anthropometric and biochemical variables in normal-weight and
overweight subjects at baseline
All subjects
n = 84
Normal weight
n = 37
Overweight
n = 47
Variable r P r P r P
Weight 0.134 0.225 0.349 0.034 20.003 0.982
BMI 0.129 0.244 0.112 0.509 0.101 0.500
Waist 0.149 0.175 0.372 0.023 20.048 0.750
Waist/hip ratio 0.172 0.118 0.398 0.015 0.018 0.905
Glucose 0.088 0.434 0.157 0.362 20.003 0.985
Insulin 0.019 0.889 0.043 0.840 0.004 0.983
HOMA 0.081 0.561 0.196 0.371 0.063 0.738
TAG 0.021 0.849 0.253 0.130 20.131 0.378
FFA 20.011 0.924 20.058 0.732 20.009 0.952
Cholesterol 20.083 0.454 20.298 0.073 20.102 0.497
HDL-C 20.078 0.480 20.058 0.732 20.078 0.601
LDL-C 20.093 0.398 20.341 0.039 20.034 0.823
All: glucose (n = 82), insulin (n = 55), HOMA (n = 54); normal-
weight: glucose (n = 36), insulin (n = 24), HOMA (n = 23); overweight:
glucose (n = 46), insulin (n = 31), HOMA (n = 31). Underlined values
indicate a statistically signiﬁcant difference.
1646 Vol. 31 April 2017 LO´PEZ-YOLDI ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by Univ of California - Davis (169.237.106.120) on June 21, 2019. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 1639-1649.
circadian patterns, a pathology that has been labeled
“chronodisruption” (49). CD suggests that rhythms can
become desynchronized and that this may have adverse
effects onhealth (50–52).CDcanbeassessed inphysiologic
studies as a reduction in rhythm amplitude, sometimes as
a total loss of rhythm, by a delayed or advanced phase
between different peripheral clocks and the SCN, or a
phase inversion of circadian rhythms, as observed in night
workers (50, 52). The current results for plasma CT-1
concentrations, suggesting a dampening of CT-1 rhythms
in overweight/obese subjects, parallel previous results
reported for the adipocyte hormones leptin, adiponectin,
and resistin. These hormones exhibit clear circadian
rhythms in24-hplasmaconcentrations, and these rhythms
are attenuated or even absent in obese individuals (53, 54).
Several factors could contribute to this, including differ-
ential metabolic responses to overnight fasting between
normal-weight and obese subjects (55). Although our
previous studieshave clearlydemonstrated that the lackof
CT-1 causes adult onset obesity in mice, the relationship
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between CT-1 circulating levels and obesity in humans is
still unclear. Thus, although some studies have reported
that obese individuals exhibit increased levels of circulat-
ing CT-1 (19, 21, 35), no significant changes in CT-1 serum
levels in overweight/obese subjects were observed in the
current or another study (56), suggesting that other factors
associated with obesity, and not the increased adiposity
directly, could determine the levels of this cytokine.
Therefore, it would be interesting to compare the 24-h
diurnal rhythm of CT-1 between healthy normal-weight
and overweight/obese individuals (matched by insulin
and HOMA levels) and lean and obese subjects with
metabolic syndrome or type 2 diabetes.
In summary, the results presented herein suggest a role
for CT-1 in the regulation of metabolic circadian rhythms
and core clock genes in adipose tissue. In addition, the
current results also indicate that circulating CT-1 concen-
trations exhibit a 24-h circadian pattern in normal-weight
subjects and that this rhythm is impaired in overweight/
obese subjects. Further research is needed to better define
the processes involved in the circadian/diurnal regulation
of CT-1 secretion and the role of CT-1 in metabolic physi-
ology and the pathophysiology of obesity.
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